These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Clinical experience with Leponex]. Lange E, König L, Kühne GE, Liefke T. Psychiatr Neurol Med Psychol (Leipz); 1975 Jun; 27(6):360-5. PubMed ID: 1208707 [Abstract] [Full Text] [Related]
10. [Long-term clozapine treatment of schizophrenic type psychoses and the significance of side-effects (author's transl)]. Zapletálek M, Preiningerová O, Pazdirek S, Hanus H, Stránský P. Cesk Psychiatr; 1977 Apr; 73(2):73-80. PubMed ID: 880672 [No Abstract] [Full Text] [Related]
15. Duration of a clozapine trial in neuroleptic-resistant schizophrenia. Meltzer HY. Arch Gen Psychiatry; 1989 Jul; 46(7):672. PubMed ID: 2567591 [No Abstract] [Full Text] [Related]
16. Who should receive clozapine? Marder SR, Van Putten T. Arch Gen Psychiatry; 1988 Sep; 45(9):865-7. PubMed ID: 2901253 [No Abstract] [Full Text] [Related]
17. [Clozapine--a new antipsychotic agent used in treatment resistance. A good effect but a great risk of adverse effects]. Wilholm BE, Myrhed M. Lakartidningen; 1989 Jul 12; 86(28-29):2508-9. PubMed ID: 2674566 [No Abstract] [Full Text] [Related]
18. [Clinical evaluation of clozapine. A follow-up study]. Wojdyslawska I, Góraj A, Soczyńska J. Psychiatr Pol; 1976 Jul 12; 10(5):497-502. PubMed ID: 981423 [No Abstract] [Full Text] [Related]